Atorvastatin cuts anthracycline heart failure

Published Date: 08 Mar 2023

Atorvastatin 40 mg daily for 12 months reduces cardiovascular events in lymphoma patients treated with anthracyclines.

Read Full News

Latest News

TADV Saves Limbs in No-Option CLTI Patients

More than 80% of no-option chronic limb-threatening ischemia patients avoided amputation for 6 months after the procedure while enjoying improved wound healing and reduced pain.

Underground Hospitals: Is Combat Medicine Entering a New Era?

Ukrainian clinicians increasingly rely on protected underground facilities as drone threats complicate evacuation and strain traditional battlefield treatment models.

France Focuses on Drugs That Raise Fall Risk in Older Adults

Long-term benzodiazepines and anticholinergics drive falls in seniors; prioritize nonpharmacologic care and deprescribing to cut injuries and hospitalizations.

Uraemic Marker Predicts Mortality After Kidney Transplant

Plasma levels of symmetric dimethylarginine are independently associated with an increased risk for mortality in adult kidney transplant recipients, a prospective study finds.

GLP-1 Drugs Tied to Cardiovascular Benefits in T1D

Adults with T1D who receive GLP-1-based therapy may have a lower risk for adverse cardiovascular outcomes and no significant increase in diabetic ketoacidosis compared with those who do not.

Transient Neurologic Symptoms: What Clinicians Miss

Speakers warn that transient neurologic events may conceal high-risk vascular disease, seizures, or amnestic syndromes requiring rapid evaluation.

Todays Updates

Hidradenitis Suppurativa Tied to Higher Cardiovascular Risks

Individuals with HS show higher risks for cardiovascular outcomes, including hypertension, coronary or ischemic heart disease, venous thromboembolism, and myocardial infarction, in a meta-analysis.

Todays Updates

Hidradenitis Suppurativa Tied to Higher Cardiovascular Risks

Individuals with HS show higher risks for cardiovascular outcomes, including hypertension, coronary or ischemic heart disease, venous thromboembolism, and myocardial infarction, in a meta-analysis.

Latest News

More than 80% of no-option chronic limb-threatening ischemia patients avoided amputation for 6 months after the procedure while enjoying improved wound healing and reduced pain.

Ukrainian clinicians increasingly rely on protected underground facilities as drone threats complicate evacuation and strain traditional battlefield treatment models.

Long-term benzodiazepines and anticholinergics drive falls in seniors; prioritize nonpharmacologic care and deprescribing to cut injuries and hospitalizations.

Plasma levels of symmetric dimethylarginine are independently associated with an increased risk for mortality in adult kidney transplant recipients, a prospective study finds.

Adults with T1D who receive GLP-1-based therapy may have a lower risk for adverse cardiovascular outcomes and no significant increase in diabetic ketoacidosis compared with those who do not.

Speakers warn that transient neurologic events may conceal high-risk vascular disease, seizures, or amnestic syndromes requiring rapid evaluation.

News All Time

Preventive Care With the Most Bang for Your Buck

An analysis of USPSTF and ACIP recommendations shows wide variation in impact, helping clinicians prioritize care during time-constrained visits.

Long Delays in Cardiac Amyloidosis Diagnosis Persist

Most older adults with transthyretin cardiac amyloidosis face a several-month delay in diagnosis after a heart failure diagnosis, despite overall increased diagnostic frequency of amyloidosis.

Early Physical Activity Safe After MI

Patients who started physical activity within a week of discharge for a heart attack have no greater cardiovascular risk than less active patients in a recent study.

Clopidogrel Beats Aspirin Long-Term After PCI

When dual antiplatelet therapy was stopped 12 months after PCI, clopidogrel monotherapy lowered cardiovascular and bleeding events relative to aspirin.

Jehovah’s Witnesses Allow Autologous Blood in Brazil

Jehovah’s Witnesses now allow members to choose to use their own blood in some procedures, reigniting debate over bloodless surgery, patient autonomy, and broader blood-conservation care.

BP After Stroke Thrombectomy: Individualization Needed?

Results of a new trial suggest that BP targets after thrombectomy in patients with acute ischemic stroke may need to be individualized depending on several different patient characteristics.

New STEMI Score Predicts Mortality After Angioplasty

A new seven factor score predicts long term mortality after ST-elevation myocardial infarction in patients who undergo angioplasty, and it performs similarly to or better than existing models.

Too Few Children With Overweight/Obesity Assessed for OSA

Children were more likely to undergo an evaluation if they had public insurance, had a higher BMI, had English as a primary language, or were a toddler or preschool aged.

Syncing Sleep, Fasting Improves Blood Sugar Markers

Patients interested in time-restricted eating should make sense it works their own sleep cycle.

Lipoprotein(a) Levels Matter Even in Primary Prevention

Elevated lipoprotein(a) levels are associated with increased non-calcified plaque volume and higher odds of high-risk features at the plaque level in adults without prior coronary artery disease.

Severe Chest Pain in Newly Diagnosed Colorectal Cancer

Case study illustrates iatrogenic risks not to be underestimated

Personalizing Treatment in Narcolepsy and Idiopathic Hypersomnia: Integrating the Latest Evidence Into Optimized Management Plans

Personalizing Treatment in Narcolepsy and Idiopathic Hypersomnia: Integrating the Latest Evidence Into Optimized Management Plans

From Detection to Decision: Anticoagulation Strategies in Subclinical Atrial Fibrillation

From Detection to Decision: Anticoagulation Strategies in Subclinical Atrial Fibrillation

Changing the Trajectory of Cardiorenal Disease: Optimizing CKD Treatment to Improve Patient Outcomes

Changing the Trajectory of Cardiorenal Disease: Optimizing CKD Treatment to Improve Patient Outcomes

Anticoagulation in the Balance: Navigating DOAC Use in NVAF and Liver Disease

Anticoagulation in the Balance: Navigating DOAC Use in NVAF and Liver Disease

Assess, Align, Act: A Practical Guide to ASCVD Risk Assessment and LDL-C Goal Setting

Assess, Align, Act: A Practical Guide to ASCVD Risk Assessment and LDL-C Goal Setting

Recommended News For You

'Sugar' signatures help identify and classify pancreatic cancer cell subtypes

New PET tracer enables same-day imaging of triple-negative breast and urothelial cancers

TULSA Is Effective in Long-Term Prostate Cancer Control.

What Could This Exploratory 5-Year Survival Data in Adjuvant NSCLC Treatment Mean?

Prostate cancer, rectal exams, Casgevy approved for thalassemia, and two million cancer cases.

Cancer research in the US is world class. With the government pulling out, its future is uncertain

Skinny melanoma incidence is associated with vitamin D deficiency.

Recommended Articles For You

Immunotherapy Breakthroughs: Transforming Cancer Care Across All Oncology Fields 

Understanding Pancreatic Cancer: Symptoms, Causes and Risk Factors  

Stomach Cancer: Uncovering the Subtle Signs and Symptoms 

Neuroendocrine Tumors: Case Study on Diagnosis, Treatment Strategies & Patient Management 

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Cancer Diagnoses Still Lagging; Cancer and Family Health; New Type of Lung Cancer

2.

Glioblastoma cells can 'unstick' from their neighbors to become more deadly

3.

Getting More Done With Less Blood.

4.

Patients with resected head and neck cancers may benefit clinically from an investigational personalized vaccine.

5.

Scientists develop novel adjuvant delivery system to enhance cancer vaccine effectiveness

1.

Exploring the Effects of Radiation Therapy on Cystitis: A Journey to Better Health

2.

Circulating Tumor Cells & Platelet Interactions: Crosstalk for Therapeutic Advances

3.

What is Mullerian and How Does it Affect Your Health

4.

The Mystery of Carotid Body Tumors: The Facts You Need to Know

5.

Unraveling the Mysteries of Coagulopathy: A Comprehensive Definition

1.

International Lung Cancer Congress®

2.

Genito-Urinary Oncology Summit 2026

3.

Future NRG Oncology Meeting

4.

ISMB 2026 (Intelligent Systems for Molecular Biology)

5.

Annual International Congress on the Future of Breast Cancer East

1.

A Comprehensive Guide to First Line Management of ALK Positive Lung Cancer - Part VII

2.

Nimotozumab Plus Chemo-radiotherapy v/s Placebo Plus Chemo-radiotherapy in Locally Advanced Nasopharyngeal Carcinoma

3.

Expert Group meeting with the management of EGFR mutation positive NSCLC - Part III

4.

Advances in Classification/ Risk Stratification of Plasma Cell Dyscrasias- The Summary

5.

Targeting Oncologic Drivers with Dacomitinib: A New Approach to Lung Cancer Treatment

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot